Oxford Biomedica PLC financial statements, including revenue, expenses, profit, and loss
The total revenue of OXBDF for the last semiannual is 59.17 M USD, and it's 8.25% higher compared to the previous semiannual. The net income of H2 23 is -139.44 M USD.